UK
Drug safety: UK and EU post-Brexit
September 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Europe, MHRA, UK, brexit, drug safety, pharmacovigilance
What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from …
NICE rejects Roche’s Ocrevus in primary progressive multiple sclerosis
September 10, 2018Sales and Marketing NICE, Ocrevus, Roche, UK, multiple sclerosis, pharma
Of the 100,000 MS patients in England, around one in eight have the primary progressive form (PPMS), which brings debilitating …
Pfizer says Brexit will cost the company $100 million
September 4, 2018Manufacturing and Production EU, Pfizer, UK, brexit, pharma
The US multinational Pfizer has said that Brexit will cost the company $100 million in costs associated with the transference …
The September 2018 issue of Pharmafocus is available to read online now!
September 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance
The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …
MHRA loses EMA contracts in wake of Brexit
September 3, 2018Sales and Marketing EMA, MHRA, UK, brexit, contracts, politics, regulation
The EMA has awarded Britain’s regulatory body the MHRA just two contracts this year, as the European agency suggested that …
Top Ten most popular articles on Pharmafile.com this week
August 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Medicare, Novartis, UK, brexit, generics, king bio, pharma, top ten
Eight months of 2018 down – where has the year gone? As we move from August into September, and a …
Contraceptive app Natural Cycles investigated over “misleading” efficacy claims
August 30, 2018Medical Communications, Sales and Marketing APP Pharma, Natural Cycles, UK, app. pharma
The company behind Natural Cycles, the first-ever approved smartphone app promising a natural alternative to contraception, has seen a Facebook …
Novartis’ Kymriah & Gilead’s Yescarta become first EU-approved CAR T therapies
August 28, 2018Manufacturing and Production, Sales and Marketing CAR T, CAR-T, Cancer, EU, Gilead, Kymriah, Novartis, UK, Yescarta, blood cancer, pharma
Almost one full year since the treatment was given a “historic” approval in the US, Novartis’ CAR T therapy Kymriah …
Government publishes no-deal Brexit guidance, health secretary tells pharma companies to stockpile medicines
August 24, 2018Medical Communications ABPI, EU, UK, brexit, government, stockpiling
The British Government has published a document offering guidance as to what should be expected in the case of a …
NICE rejects Biogen’s spinal muscular dystrophy drug Spinraza after long delay
August 14, 2018Manufacturing and Production, Sales and Marketing Biogen, NICE, Spinraza, UK, pharma, spinal muscular dystrophy
UK watchdog NICE has rejected Biogen’s spinal muscular dystrophy drug Spinraza (nusinersen) over cost concerns, denying patients the only available …
NHS scraps restriction on availability of J&J’s Imbruvica in leukaemia patients
August 10, 2018Medical Communications, Sales and Marketing Cancer, J&J, JJ, Johnson & Johnson, NHS, NICE, UK, imbruvica, leukaemia, pharma
The NHS has dropped a controversial restriction preventing leukaemia patients from accessing Johnson & Johnson’s tyrosine kinase inhibitor Imbruvica (ibrutinib), …
Top Ten most popular articles on Pharmafile.com this week
August 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ADHD, Allergan, MHRA, UK, brexit, iraq, pharma, top 10
There was some clarity on Brexit this week as the MHRA set out a plan for the implantation period set …
ABPI Chief warns of Brexit impact on EU
August 10, 2018Medical Communications ABPI, EU, UK, brexit, trade lobby
The head of the Association of the British Pharmaceutical Industry (ABPI) has warned that European governments have failed to recognise …
MHRA sets out Brexit implementation period plan
August 7, 2018Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, MHRA, UK, brexit, implentation period
The UK Medicines and Healthcare products Regulatory Agency (MHRA) have released an update which sets out what pharmaceutical and healthcare …
EMA to cut activities as it forecasts loss of 30% of staff
August 2, 2018Medical Communications, Research and Development EMA, London, UK, amsterdam, brexit, disruption, staff
The European Medicines Agency is set to enact temporary cuts in activities as it prepares for significant disruption in the …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
